The $500 billion Stargate project will be critical to "maintain American leadership in AI," one of the partners said in a statement.

Yes, that's the name of a 1994 Roland Emmerich movie. It's now a big infrastructure project to help power tech giants' foray into AI.

Oracle Corporation witnessed a significant surge in its stock, jumping 7% on Tuesday, following reports of its involvement in a groundbreaking joint venture to enhance artificial intelligence (AI) infrastructure in the United States.

As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals developing artificial intelligence.

The $500B Stargate Initiative, led by Trump, OpenAI, SoftBank, and Oracle, is set to revolutionize U.S. AI infrastructure.

Nvidia’s market valuation surpassed Apple’s on Tuesday, making it the world’s most valuable publicly traded business once more. TakeAway Points: Nvidia’s market valuation overtook Apple’s, making it the world’s most valuable publicly traded business once more.

Donald Trump says his big new AI initiative is a victory for America. Guess who the real winner is.

US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.

President Donald Trump held a press conference to announce Stargate, a $500 billion artificial intelligence (AI) infrastructure project in the United States. He called it the "largest AI infrastructure project,

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early through a simple blood test, followed by gene sequencing of the tumour